Author

Akihiro Yoshida

University Hospitals of ClevelandORCID 0000-0002-9785-9035Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ankit ManglaiD· 1 shared Ayanesh Kumar· 1 shared Bryce Brunetti· 1 shared Justin KimiD· 1 shared Kord S. Honda· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ankit ManglaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cells.

Justin Kim, Bryce Brunetti, Ayanesh Kumar, Ankit Mangla, Kord S. Honda, Akihiro Yoshida

This paper shows that inhibiting glutaminase 1 (GLS1) kills senescent melanoma cells induced by CDK4/6 inhibitors, even when those cells are resistant to BRAF inhibitors.

Cell Death and Disease · Dec 18, 2024Peer-reviewedCancer Biology